Problems paying for prescription drugs Source: Montero, et al KFF, November 14, 2025 Implications for employers: Plan member interest in GLP-1 medications to treat obesity and cardiometabolic disease is likely to continue to increase
When obesity treatment accelerates weight loss, the risk of worsening sarcopenia may increase if preventive measures are not implemented
serves on scientific advisory board for the American Medical Association, American College of Cardiology (board of trustees member), Society for Cardiovascular Angiography and Interventions (Women in Innovations committee member), and an associate editor at JAMA
Enhance mental clarity Improved NAD+ levels promote cognitive function, focus, and overall brain health
Exercise: Regular exercise can increase glutathione levels